Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A blocking peptide from human RPL22.
Synthetic
(Accession #: NP_033105) SKRYLKYLTKKYLKKNNLRDWLRVVANSKESYELRYFQINQDEEEEEDED The RPL22 Blocking Peptide is derived from Synthetic. The RPL22 Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-047514 |
| Réf. fabricant | 18094669 |
| Gene ID (Entrez) | 6146 |
| Espèces | Human, Mouse |
| Nom usuel | RPL22 |
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
| Formule | Lyophilized with sterile distilled water. |
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-98446. This Synthetic Peptide is Designed for Use in an Antibody Competition Assay with Its Corresponding Antibody. Use of This Product in Any Other Assay Has Not Yet Been Tested. For Further Blocking Peptide Related Protocol, Click Here . |
| Alias de gène | EAPHBP15, EBER-associated protein, Epstein-Barr virus small RNA-associated protein, Epstein-Barr-encoded RNA-associated protein, HBP15/L22, heparin-binding protein 15, Heparin-binding protein HBp15, ribosomal protein L22,60 S ribosomal protein L22 |
| Symbole de gène(s) | RPL22 |
| Poids moléculaire | TMW: 15kDa |
| Quantité | 100 μg |
